In Brief: FDA Blood Products Advisory Committee
Executive Summary
FDA Blood Products Advisory Committee: Will meet Sept. 26 to discuss detection of HIV-1 Group "O" and the possible transmission of hepatitis C by immune globulin. In the afternoon, the committee will discuss Novo Nordisk's recombinant Factor VIIa. The committee will sit as a medical device panel Sept. 27. The committee will meet starting at 8 a.m. both days at the Holiday Inn, Bethesda, Md...